Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Breast Neoplasm
Interventions: DRUG: Pazopanib
Sponsor: Hope Rugo, MD
Collaborators: GlaxoSmithKline